PE-conjugated Anti-CLEC4C (litifilimab biosimilar) mAb

Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Description: PE-conjugated Anti-CLEC4C (litifilimab biosimilar) mAb

Storage & Shipping: Store at 2°C-8°C fo 6 months

Formulation & Reconstitution: Liquid，PBS with 0.05% Proclin300, 326% BSA

Target: CLEC4C

Uniprot ID: Q8WTT0

Usage: Research use only

Recommended Dilutions: Flow Cyt 1:100

Common Name: BIIB 059, BIIB-059, BIIB059

Guarantee: 6 months from date of dispatch

• Artikelnummer: DMABME100155P-100
• Hersteller: DIMA Biotechnology
• Hersteller Artikelnummer: BME100155P-100
• Verpackungseinheit: 100 test
• Mengeneinheit: STK
• Reaktivität: Human
• Methode: Flow Cytometry
• Isotyp: IgG1(E239D, M241L)
• Wirt: Human
• Konjugat: Conjugated, PE (Phycoerythrin)